You are here

Article info

Article menu
XML
Clinical/translational cancer immunotherapy
Original research
TGM4: an immunogenic prostate-restricted antigen

Authors

  • Zoila A Lopez-Bujanda Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USAColumbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York, USABloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USACurrent: Molecular Pathogenesis Program, The Kimmel Center for Biology and Medicine of the Skirball Institute, New York University School of Medicine, New York, NY, USA PubMed articlesGoogle scholar articles
  • Aleksandar Obradovic Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Thomas R Nirschl Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USABloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Laura Crowley Department of Genetics and Development, Columbia University Irving Medical Center, New York, New York, USAHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York, USADepartment of Medicine, Columbia University Irving Medical Center, New York, New York, USADepartment of Systems Biology, Columbia University Irving Medical Center, New York, New York, USADepartment of Urology, Columbia University Irving Medical Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Rodney Macedo Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Alexandros Papachristodoulou Herbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York, USADepartment of Molecular Pharmacology and Therapeutics, Columbia University Irving Medical Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Timothy O’Donnell Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA PubMed articlesGoogle scholar articles
  • Uri Laserson Department of Genetics and Genomic Sciences, Icahn School of Medicine at Mount Sinai, New York, New York, USA PubMed articlesGoogle scholar articles
  • Jelani C Zarif Bloomberg~Kimmel Institute for Cancer Immunotherapy, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USADepartment of Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Ran Reshef Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York, USADivision of Hematology Oncology, Columbia University Irving Medical Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Tiezheng Yuan Division of Immunology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USAInstitute of Cell Engineering, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Mithil K Soni Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Emmanuel S Antonarakis Department of Oncology, Johns Hopkins Medicine Sidney Kimmel Comprehensive Cancer Center, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Michael C Haffner Divisions of Human Biology and Clinical Research, Fred Hutchinson Cancer Research Center, Seattle, Washington, USA PubMed articlesGoogle scholar articles
  • H Benjamin Larman Division of Immunology, Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USAInstitute of Cell Engineering, Johns Hopkins University, Baltimore, Maryland, USA PubMed articlesGoogle scholar articles
  • Michael M Shen Department of Genetics and Development, Columbia University Irving Medical Center, New York, New York, USAHerbert Irving Comprehensive Cancer Center, Columbia University Irving Medical Center, New York, New York, USADepartment of Medicine, Columbia University Irving Medical Center, New York, New York, USADepartment of Systems Biology, Columbia University Irving Medical Center, New York, New York, USADepartment of Urology, Columbia University Irving Medical Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Pawel Muranski Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York, USADepartment of Medicine, Columbia University Irving Medical Center, New York, New York, USA PubMed articlesGoogle scholar articles
  • Charles G Drake Columbia Center for Translational Immunology, Columbia University Irving Medical Center, New York, New York, USADepartment of Urology, Columbia University Irving Medical Center, New York, New York, USADivision of Hematology Oncology, Columbia University Irving Medical Center, New York, New York, USA PubMed articlesGoogle scholar articles
  1. Correspondence to Dr. Charles G Drake; cgd2139{at}cumc.columbia.edu
View Full Text

Citation

Lopez-Bujanda ZA, Obradovic A, Nirschl TR, et al
TGM4: an immunogenic prostate-restricted antigen
Journal for ImmunoTherapy of Cancer 2021;9:e001649. doi: 10.1136/jitc-2020-001649

Publication history

  • Accepted March 8, 2021
  • First published June 30, 2021.
Online issue publication 
February 24, 2022

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ. http://creativecommons.org/licenses/by-nc/4.0/This is an open access article distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited, appropriate credit is given, any changes made indicated, and the use is non-commercial. See http://creativecommons.org/licenses/by-nc/4.0/.